Nous utilisons des cookies
En cliquant sur « Accepter », vous acceptez que des cookies soient stockés sur votre appareil afin d'améliorer la navigation sur le site, d'analyser l'utilisation du site et de nous aider dans nos efforts de marketing. Consultez nos mentions légales pour plus d'informations.

Why Enosium Life Science

OUR Purpose

Meeting the challenges of health innovation

Pharmaceutical, biotechnology, and medtech companies face major challenges in commercializing their health products and innovations.
Acceleration of scientific and technological innovation
High R&D costs and associated risks
Complexity, fragmentation, and uncertainties of EU regulations
Limited funding and pressure on access prices
Growing societal demand for healthcare
Our positioning

Integrated services across the entire value chain

Enosium Life Science deploys a model combining scientific expertise, in-depth knowledge of the local ecosystem, and international coordination.
Our expertise
founder & ceo

Antoine Amer, MD

Antoine Amer, 50 years old, a physician holding an MBA from ESCP and Harvard Business School, has over 20 years of experience in the pharmaceutical industry. He has led commercial operations in Europe and globally for renowned pharmaceutical companies: MSD, Servier, AbbVie, and Indivior.
As the CEO of Enosium Life Science, his mission is to bring together the best scientific services companies to create a leading group in Europe within the next 5 years.
Our expertise
Our financial partner

Otium : a major player in private investment in Europe

Enosium Life Science is supported by Otium, a leading European investment firm that supports ambitious entrepreneurs ready to disrupt their markets.
Learn more about Otium